Please enter an amount you wish to donate and Add to Basket.
Plymouth University is building a prestigious £17 million facility to provide a research-intensive environment to investigate cancer; infection, immunity and inflammation; & neurodegenerative diseases, including:
Brain tumours, dementia, Parkinson’s, Huntington’s, antibiotic resistance, oral cancer, non-Hodgkins lymphoma, Ebola and bovine tuberculosis.
Fit for world-leading scientists, this state-of-the-art facility will have a transformative effect on the medical landscape within the region while enhancing the impact of the University’s research, both locally and internationally. It will enhance synergies, derived from collaborative working between researchers and clinicians, to attract national and global research expertise.
Ultimately, this critical development will drive advances in a number of life-threatening conditions, many of which have no cure or effective treatment, including brain tumours, dementia, Parkinson’s disease,
Huntington’s disease, Ebola, and Bovine Tuberculosis.
The facility will augment what is fast becoming a hub of world-class expertise for health and medicine, sitting alongside Derriford Hospital, medical companies, the Peninsula Clinical Trials Unit and the NIHR Peninsula Clinical Research Network.
The future of medical research in the region gives us cause for optimism: we will find ways to improve the lives of the communities we serve and the people who are affected by serious diseases around the world.